Callio Therapeutics
Similar Companies Hiring
We are developing next-generation, multi-payload antibody-drug conjugates (ADCs) that feature differentiated payload and linker technologies.
This enables targeted delivery of drug combinations to tumor cells to maximize therapeutic benefit for cancer patients. Our lead program is a dual-payload HER2-targeted ADC.
Callio Therapeutics Offices
OnSite Workspace
Employees work from physical offices.
Typical time on-site:
None
Seattle, Washington, USA
